Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCGR | P47871 | 11/20 | 0.68 |
| ▸ | ADCYAP1R1 | P41586 | 5/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9072061 | 0.81 | GCGR (1.00) | GCGRADCYAP1R1 | |
| SCHEMBL22221453 | 0.81 | GCGR (0.56) | GCGRMEN1KMT2AALDH1A1POLB | |
| SCHEMBL7228188 | 0.79 | TP53 (0.43) | GCGRALDH1A1POLBMAPT | |
| SCHEMBL2650470 | 0.76 | GCGR (0.64) | GCGRADCYAP1R1MEN1KMT2APOLB | |
| SCHEMBL2649370 | 0.76 | GCGR (0.61) | GCGRADCYAP1R1MEN1KMT2AALDH1A1 | |
| SCHEMBL2650467 | 0.75 | GCGR (0.62) | GCGRADCYAP1R1MEN1KMT2AALDH1A1 | |
| SCHEMBL9072060 | 0.75 | GCGR (0.60) | GCGRADCYAP1R1MEN1KMT2AALDH1A1 | |
| SCHEMBL24697396 | 0.74 | SMN1; SMN2 (0.51) | GCGRMEN1KMT2AALDH1A1POLB | |
| SCHEMBL2649191 | 0.74 | ADCYAP1R1 (0.65) | GCGRADCYAP1R1MEN1KMT2AALDH1A1 | |
| SCHEMBL2649190 | 0.74 | ADCYAP1R1 (0.65) | GCGRADCYAP1R1MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6613942-B1 | Nonpeptide; 4-hydroxy benzoic acid hydrazides | NOVO NORDISK A/S (DK) | 2003-09-02 | — | — | US | disclosed |